50% increases of survival rate of in-hospital cardiac arrest 

About US

At AlephBot, we are committed to transforming the landscape of medical procedures and clinical decision-making. Our cutting-edge technology is designed to empower medical teams, enhance patient outcomes, and redefine the way we approach critical healthcare scenarios. With a groundbreaking platform and a patented innovation at the Proof of Concept (PoC) stage, AlephBot is poised to revolutionize the world of healthcare.

Mission : Increase survival rate of in-hospital cardiac arrest

Empowers best clinical decisions

AlephBot is on a mission to maximize the efficiency of medical treatment during and after procedures. Our platform provides real-time, adaptive information to medical teams, ensuring that every decision is well-informed and every action is optimized.

The AlephBot Advantage

AlephBot's platform boasts a myriad of advantages that cater to the evolving needs of the healthcare industry:

Our First product: smart resuscitation station

The Challenge: In-Hospital Cardiac Arrest (IHCA) Survival Rate

In-Hospital Cardiac Arrest is a critical scenario where every second counts. With survival rates ranging from 9% to 38%, the American Heart Association reports an average of 25%. Research indicates that human factors play a pivotal role in this disparity.

The Solution: AlephBot Smart Resuscitation Station

AlephBot's "Smart Resuscitation Station" aims to significantly increase the survival rate of IHCA by addressing the human factor challenge head-on. Our innovative system is designed to infuse human factors into the procedure without the need for additional team members. We understand the pressure medical teams face and the potential pitfalls they encounter during high-stress situations.

How it Works:

UI: Smart Resuscitation Station 

Lower quality procedures receive more AlephBot alerts

Transforming ACLS Procedures: Data-Driven Excellence

At AlephBot, we believe in the power of data to drive transformative change in healthcare.

Our commitment to innovation is backed by tangible results from a recent analysis of the data collected during Advanced Cardiac Life Support (ACLS) training procedures in hospital environments. This analysis provides compelling evidence of how AlephBot can significantly enhance the quality and outcomes of ACLS procedures.

Key Insights from Our Analysis

Our data analysis revealed a striking correlation between the potential use of AlephBot's technology and the quality of ACLS procedures. Here are the key findings:

Unlocking the Future of Healthcare:
Seeking a Buyer for AlephBot 

By integrating AlephBot technology, hospitals have the potential to dramatically enhance the efficacy of their resuscitation efforts. The potential os real-time alerts, adaptive guidance, and continuous feedback offered by AlephBot can bridge the gap between medical knowledge and its successful implementation, resulting in higher success rates and improved patient outcomes.